While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These ...

KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG, Bloomberg News reported on Thursday, citing people familiar with the matter. Warburg Pincus, which was also a ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

President Trump has announced sweeping tariffs on several countries. Novo Nordisk and Smith & Nephew may be the most at risk ...

Here's everything you need to know about the new weight loss medication being rolled out by the NHS to treat obesity.

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.